GPT and metabolic dysfunction-associated steatotic liver disease: Standard laboratories separated patients with NAFLD from controls including significant increase in ALT, aspartate aminotransferase (AST) and gamma-glutamyl transferase (γGT) activity as well as fasting lipid profiles and uric acid concentration.